Its praised for its potential in tissue repair and anti-inflammatory properties, making it an appealing option for those looking to boost recovery from injuries
Its used for inflammatory conditions as well as tissue repair, tendon and ligament healing
There has been limited research examining the efficacy of BPC-157 in humans, and the peptide has yet to receive formal approval for any therapeutic use
As early adopters and long-time researchers deeply fascinated by the potential of peptides, we spent years navigating an industry that often felt like the Wild West
BPC-157 is a 15-residue, 1419.53 g/mol pentadecapeptide whose mechanistic literature centres on local angiogenic signalling, Hsieh and colleagues (J Mol Med, 2017) reported upregulation and internalisation of VEGFR2 in human endothelial cells, and Chang and colleagues (J Appl Physiol, 2011) reported increased FAK and paxillin phosphorylation with greater outgrowth and migration in cultured rat tendon fibroblasts